ResMed Inc (STU:RME)
€ 238 -0.2 (-0.08%) Market Cap: 33.56 Bil Enterprise Value: 33.96 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 98/100

Resmed Inc Investor Meeting Transcript

Apr 04, 2019 / 09:30PM GMT
Release Date Price: €89.76 (-3.04%)
Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

All right, let's go ahead and get started. I want to thank everyone for coming this afternoon. Thanks for joining us here in San Diego. I know it's the end of a long -- what's been a long week or multiple weeks for some of you. And thank you to everyone joining us on the webcast as well, and we're looking forward to sharing the next couple of hours with you to share some more information about ResMed specifically and some of our recent acquisitions and around our long-term strategy. I think we've got a great lineup for you this afternoon.

So housekeeping items for you. As a reminder, forward-looking statements are subject to risks and uncertainties, actual results could differ.

Rob's going to cover the agenda. But before we get into that, I just want to let everyone know, after prepared remarks, we will host a Q&A session. For the folks in the room, just raise your hand and wait for us to bring a mic over. We would like to capture that for the transcript. We are recording this, and we'll post the transcript and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot